Strategic Initiative
Slingshot members are tracking this corporate initiative:
Assertio Therapeutics (ASRT) Announces Closing of Sale of NUCYNTA Franchise to Collegium Pharmaceutical (COLL) for $375.0 Million
Do you think this event is important to the companies below? How will it affect their stock price?
Additional Information
Under the terms of the agreement, Collegium paid Assertio $375.0 million in cash at closing, less royalties paid to Assertio in 2020. Collegium paid Assertio for certain inventories and equipment relating to the products.Stifel acted as exclusive financial advisor to Assertio in this transaction and Gibson, Dunn & Crutcher LLP and Greenberg Traurig LLP served as legal counsel.Additional details can be found in the Company’s Form 8-K filed with the Securities and Exchange Commission.
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Feb 13, 2020 Relevance Tracked Until: Q2, 2020
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Nucynta